Gilbert + Tobin’s Competition and Regulation group is extending its market-leading practice by attracting a new hire.
Susan Jones, ex-head of the global antitrust practice at Swiss healthcare company Novartis, has left her role after more than a decade to join Gilbert + Tobin on 17 June, as a special counsel in the Melbourne office.
Susan will bring a wealth of expertise and knowledge from her time in-house at Novartis. There she oversaw a series of high-profile transformational deals including the GSK and Lilly merger clearances and more recently, the €791 million sale of its Sandoz division’s dermatology business and generic assets to Aurobindo. Prior to Novartis, Susan was a senior associate at Allen & Overy in Brussels and a senior investigator at the Australian Competition and Consumer Commission (ACCC).
“I’m excited to join Gilbert + Tobin, which has a strong reputation in competition law and a great team that has a culture of collaboration, innovation, performance and client service. I’m also impressed by Gilbert + Tobin’s high proportion of female partners and a commitment to good corporate citizenship,” Susan said.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
UK’s CMA Investigates Education Software Company for Market Abuse
May 14, 2024 by
CPI
Schumer Urges FTC Caution on Chevron’s $53B Hess Deal Over Gas Price Fears
May 14, 2024 by
CPI
Amazon Urges US Judge to Block FTC Probe into Data Preservation
May 14, 2024 by
CPI
Colorado Makes History: First State to Enact Comprehensive AI Legislation
May 14, 2024 by
CPI
Class Action Settlement Reached in Cheerleading Monopoly
May 14, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Ecosystems
May 9, 2024 by
CPI
Mapping Antitrust onto Digital Ecosystems
May 9, 2024 by
CPI
Ecosystems and Competition Law: A Law and Political Economy Approach
May 9, 2024 by
CPI
Ecosystem Theories of Harm: What is Beyond the Buzzword?
May 9, 2024 by
CPI
Open Ecosystems: Benefits, Challenges, and Implications for Antitrust
May 9, 2024 by
CPI